Literature DB >> 2443533

Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

E C Short1, R W Fulton.   

Abstract

2',5'-Oligoadenylate [2',5'-oligo(A)] was separated from 14C-labeled nucleosides produced in the 2',5'-oligo(A) synthetase assay by using 100-microliters columns of Dowex 1. No detectable nucleoside remained on the column after elution with 20 column volumes of water, whereas less than 1% of oligonucleotides were eluted from the column. At least 99% of oligonucleotides were eluted from the column with 1 M NaCl, pH 2. The major product had properties consistent with 2',5'-oligo(A). Exposure to alpha-1 bovine interferon (IFN) caused an increase in cellular 2',5'-oligo(A) synthetase activity which was proportional to the concentration of IFN in the medium up to 10(4) U of IFN per ml and then leveled off at about 15 X control activity. Under the assay conditions used, 2',5'-oligo(A) synthetase activity was directly proportional to the amount of cell extract over a 10-fold range. Cattle inoculated with IBR/BVD/PI-3 modified live virus vaccine showed an increase in 2',5'-oligo(A) synthetase activity in peripheral blood mononuclear leukocytes which persisted for at least 3 days postvaccination. Intramuscular injection of cattle with IFN caused a similar increase in 2',5'-oligo(A) synthetase activity. Changes in 2',5'-oligo(A) synthetase activity should be of value in (i) assessing the response of cattle to experimental viral infections or inoculations with viral vaccines or IFN or (ii) indicating a possible viral etiology in disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443533      PMCID: PMC269318          DOI: 10.1128/jcm.25.9.1735-1740.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis.

Authors:  W K Roberts; A Hovanessian; R E Brown; M J Clemens; I M Kerr
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

2.  Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA.

Authors:  I M Kerr; R E Brown; A G Hovanessian
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

3.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  An improved method for thin-layer chromatography of nucleotide mixtures containing 32P-labelled orthophosphate.

Authors:  M Cashel; R A Lazzarini; B Kalbacher
Journal:  J Chromatogr       Date:  1969-03-11

5.  Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells.

Authors:  A G Hovanessian; R E Brown; I M Kerr
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

6.  Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation.

Authors:  L Ratner; R C Wiegand; P J Farrell; G C Sen; B Cabrer; P Lengyel
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

7.  Non-appearance of injected fibroblast interferon in circulation.

Authors:  V G Edy; A Billiau; P De Somer
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321

8.  Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

Authors:  M J Clemens; B R Williams
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

9.  General considerations of the interferon system.

Authors:  S Baron; F Dianzani
Journal:  Tex Rep Biol Med       Date:  1977

10.  Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.

Authors:  H Sugino; I Mitani; M Koike; T Kodama; J Sokawa; H Sawai; K Ishibashi; M Itoh; S Watanabe; Y Sokawa
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.